La utilidad del número necesario de pacientes a largo plazo a tratar para evaluar las terapias inhibidoras de las interleucinas 17 y 23 en el tratamiento de la psoriasis en placas de moderada a grave / The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis
Actas dermo-sifiliogr. (Ed. impr.)
; 115(4): 427-429, Abr. 2024. tab
Article
in Es
| IBECS
| ID: ibc-232027
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Patients
/
Psoriasis
/
Interleukin-17
/
Interleukin-23
Limits:
Female
/
Humans
/
Male
Language:
Es
Journal:
Actas dermo-sifiliogr. (Ed. impr.)
Year:
2024
Document type:
Article